Edwards Lifesciences is specializing in patient-focused medical innovations for structural heart disease and critical care monitoring. The company is dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.

Edwards Lifesciences (Israel) Ltd operates as a subsidiary of Edwards Lifesciences Corporation. The Israeli R&D center was opened after the acquisition of Percutaneous Valve Technologies in 2003 and focuses on the development of percutaneous heart valves and other percutaneous techniques for heart valve repair and replacement.

The Edwards Israel Innovation Center (EIIC) focuses on developing early-stage cardiovascular technologies. Our passion, ingenuity, collaboration, and new ways of thinking enable us to develop devices and therapies that help patients around the world. Our commitment to a diverse and inclusive work culture welcomes all perspectives to help us thrive. We invite mission-driven employees in engineering, quality assurance, regulatory affairs, cyber security & data analytics and more to join us to impact patients' lives.